Hundreds of patients, advocates, and other stakeholders will be taking part in this historical movement by meeting with members of Congress in support of the Compassionate Access, Research Expansion, and Respect States (CARERS) Act on March 22nd.
Republican Senator Rand Paul of Kentucky, along with Democratic Senators Corey Booker of New Jersey and Kirsten Gillibrand of New York, introduced the Compassionate Access, Research Expansion, and Respect States, or CARERS Act, at a Capitol Hill press conference.
From our founders' early direct action on the lawns of Genentech to demand compassionate access to a promising new drug to our work to overturn the human BRCA 1&2 gene patents, we have been working to ensure that treatments, technologies, and tests are accessible to the women who need them.
Congress has a viable option in front of them in the bipartisan Compassionate Access, Research Expansion, and Respect States Act (CARERS) Act of 2015, sponsored in the Senate by Cory Booker (D-NJ), Rand Paul (R-KY), and Kirsten Gillibrand (D-NY) and in the House by Steve Cohen (D-TN) and Don Young (R-AK).
The naltrexone implants used for management of heroin dependence were manufactured by 'Go Medical' industries in Perth, Western Australia, under Commonwealth of Australia Therapeutic Goods Administration (TGA) Good Manufacturing Practice (GMP) conditions and administered under the compassionate access arrangements of the Special Access Scheme authorised by the TGA as described elsewhere.
In March, Democratic Senators Cory Booker and Kirsten Gillibrand teamed up with Republican Senator Rand Paul of Kentucky to introduce the Compassionate Access, Research Expansion and Respect States (CARERS) Act.
The Compassionate Access, Research Expansion, and Respect States Act (CARERS) Act of 2015 is the most comprehensive piece of federal medical marijuana legislation ever introduced in the U.S. Congress.
An analysis of patients with AML treated with azacitidine on French and Italian compassionate access programs reports similar response rates ranging between 21 and 32%.
Called the Compassionate Access, Research Expansion, and Respect States (CARERS) Act, the Senate bill 683 would also move the federal classification of marijuana a step closer to a rationally defensible one.
One of the few published reports took place in Europe, where miltefosine was used within the Compassionate Access Programme for those HIV patients in whom previous treatment for VL had failed.
